Literature DB >> 22316090

Delayed entry into HIV medical care after HIV diagnosis: risk factors and research methods.

Samuel M Jenness1, Julie E Myers, Alan Neaigus, Julie Lulek, Michael Navejas, Shavvy Raj-Singh.   

Abstract

Timely linkage to HIV medical care has the potential to improve individual health outcomes and prevent secondary HIV transmission. Recent research found that estimates of delayed care entry varied by study design, with higher estimates among studies using only HIV case surveillance data. In this analysis, we compared the prevalence and risk factors for care delay using data from two studies with different designs conducted in New York City. The Medical Monitoring Project (MMP) used a retrospective design to estimate historical delay among persons currently receiving care, while the Never in Care (NIC) study used a prospective design to estimate current delay status among persons who were care-naive at baseline. Of 513 MMP subjects in 2007-2008, 23% had delayed care entry greater than three months after diagnosis. Independent risk factors for care delay were earlier year of diagnosis and testing positive in a nonmedical environment. Of 28 NIC subjects in 2008-2010, over half had tested positive in a nonmedical environment. The primary-stated reasons for delay were the same in both studies: denial of HIV status and lack of perceived need for medical care. The strengths and weaknesses of surveillance only, prospective, and retrospective study designs with respect to investigating this issue are explored. Future studies and interventions should be mindful of the common selection biases and measurement limitations with each design. A triangulation of estimates from varying designs is suggested for accurately measuring care linkage efforts over time.

Entities:  

Mesh:

Year:  2012        PMID: 22316090     DOI: 10.1080/09540121.2012.656569

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  21 in total

1.  Engagement in the HIV Care Continuum among Key Populations in Tijuana, Mexico.

Authors:  Laramie R Smith; Thomas L Patterson; Carlos Magis-Rodriguez; Victoria D Ojeda; Jose Luis Burgos; Sarah A Rojas; María Luisa Zúñiga; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2016-05

2.  Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.

Authors:  Patricia Sweeney; Lytt I Gardner; Kate Buchacz; Pamela Morse Garland; Michael J Mugavero; Jeffrey T Bosshart; R Luke Shouse; Jeanne Bertolli
Journal:  Milbank Q       Date:  2013-07-08       Impact factor: 4.911

3.  Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.

Authors:  Marya Gwadz; Charles M Cleland; Elizabeth Applegate; Mindy Belkin; Monica Gandhi; Nadim Salomon; Angela Banfield; Noelle Leonard; Marion Riedel; Hannah Wolfe; Isaiah Pickens; Kelly Bolger; DeShannon Bowens; David Perlman; Donna Mildvan
Journal:  AIDS Behav       Date:  2015-10

4.  Behind the cascade: analyzing spatial patterns along the HIV care continuum.

Authors:  Michael G Eberhart; Baligh R Yehia; Amy Hillier; Chelsea D Voytek; Michael B Blank; Ian Frank; David S Metzger; Kathleen A Brady
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

5.  High prevalence of late presentation of ART-naïve perinatally infected children for care in Pune, India.

Authors:  Smita Nimkar; Aarti Kinikar; Amol Chavan; Shashikala Sangle; Bharatbhushan Rewari; Amita Gupta; Vidya Mave; Ivan Marbaniang
Journal:  AIDS Care       Date:  2020-02-18

6.  Racial/Ethnic Disparities in Failure to Initiate HIV Care: Role of HIV Testing Site, Individual Factors, and Neighborhood Factors, Florida, 2014-2015.

Authors:  Mary Jo Trepka; Diana M Sheehan; Kristopher P Fennie; Daniel E Mauck; Spencer Lieb; Lorene M Maddox; Theophile Niyonsenga
Journal:  J Health Care Poor Underserved       Date:  2018

7.  Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens.

Authors:  Silvia Baroncelli; Maria Franca Pirillo; Clementina Maria Galluzzo; Anna Degli Antoni; Nicoletta Ladisa; Daniela Francisci; Gabriella d'Ettorre; Daniela Segala; Angela Vivarelli; Federica Sozio; Oscar Cirioni; Liliana Elena Weimer; Vincenzo Fragola; Giustino Parruti; Marco Floridia
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

8.  Antiretroviral therapy for the prevention of HIV transmission: what will it take?

Authors:  Margaret L McNairy; Wafaa M El-Sadr
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079

9.  Linkage, engagement, and viral suppression rates among HIV-infected persons receiving care at medical case management programs in Washington, DC.

Authors:  Sarah Willis; Amanda D Castel; Tashrik Ahmed; Christie Olejemeh; Lawrence Frison; Michael Kharfen
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

10.  Retention in care within 1 year of initial HIV care visit in a multisite US cohort: who's in and who's out?

Authors:  Ellen M Tedaldi; James T Richardson; Rachel Debes; Benjamin Young; Joan S Chmiel; Marcus D Durham; John T Brooks; Kate Buchacz
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.